Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SCRI-CAR22v2 |
Trade Name | |
Synonyms | SCRI-CAR22v|SCRICAR22v2 |
Drug Descriptions |
SCRI-CAR22v2 cells are T-cells engineered to express a chimeric antigen receptor (CAR) that targets CD22, which may potentially inhibit growth of CD22-expressing tumor cells (NCI Drug Dictionary). |
DrugClasses | CD22 Immune Cell Therapy 15 |
CAS Registry Number | NA |
NCIT ID | C176568 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
SCRI-CAR22v2 | SCRI-CAR22v2 | 0 | 1 |